Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[265 Pages Report] Global Oxytocin market are set to experience a significant growth of 9.0% CAGR from 2022 to 2030, with an estimated market value of around US$ 83.0 Mn as of 2022. As per Future Market Insights’ projections, Postpartum type holds a substantial share of over 88.8% in 2021 within the Global market.
Data Points | Market Insights |
---|---|
Market Value 2021 | US$ 76.0 Million |
Market Value 2022 | US$ 83.0 Million |
Market Value 2030 | US$ 164.9 Million |
CAGR 2022-2030 | 9.0% |
Market Share of Top 5 Countries | 51.2% |
Key Market Players | Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International plc. (Par Sterile Products, LLC), Teva Pharmaceutical Industries Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 8.41% |
H1, 2022 Projected | 8.96% |
H1, 2022 Outlook | 8.96% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (+) 45 ↑ |
As compared to H1-2021, the oxytocin market is expected to surge by 45 basis point share (BPS) in H1-2022 (O), according to FMI. However, comparison analysis for the H1-2022 projected and H1-2022 outlook period reflected a decline in growth rate by nearly 10 BPS.
The use of high-quality injectable oxytocin to effectively prevent and treat postpartum haemorrhage, the main cause of maternal death worldwide, is one of the key reasons contributing to the rise in BPS.
FMI provides a comparative study of the global oxytocin market's growth rates and development prospects. Market authorization and regulatory approvals, as well as the impact of macro and industrial factors, have an impact on the market. The introduction of FDA-approved exogenous oxytocin in the antepartum phase for enhancing uterine contractions with the goal of a successful vaginal birth of the foetus is a key development in this sector.
The thermal sensitivity of oxytocin, which can result in its quality being deteriorated at several points along the health supply chain, including at the manufacturing site owing to low quality of API, a dearth of sterile production systems, or poor production methods, and during storage and transport caused by a lack of temperature regulation in the distribution network, including co-packaging, can conversely provide a restrictive growth impact on the oxytocin market.
The Oxytocin market holds nearly 6.3% of the overall US$ 1.2 Bn Growth Hormones market in 2021.
The market of oxytocin on a global scale is considered extremely fragmented, with numerous local and multinational players active. Most products purchased from local players are provided by the National Government Procurement Agencies to the local governments. Thus, several developing countries are dependent upon local players, leading to an increase in focus on procurement of high volumes for lower costs.
The global oxytocin market includes an increase in the licensing activities of companies to develop new therapeutics for a range of indications.
The global oxytocin industry is set to be driven by factors including the rapidly growing global birth rate as well as the raised complications associated with birth. The overuse of caesarean delivery is expected to grow in the future which can create an unmet need of oxytocin treatment in the market. The pregnancy awareness programs offered by the local governments, NGOs and regulatory bodies are further expected to increase the awareness about the pregnancy care and healthcare setup based birth in the developing regions. The increasing awareness about pregnancy and the complications associated with it are thus the factors likely to ascend the boost in sales of oxytocin based products, thus increasing the market share growth of the oxytocin industry.
Rising demand for healthcare setup based pregnancy births and developments of high quality oxytocin therapeutics are re-shaping the therapeutic landscape in haemorrhage treatment in pregnancy. The current trend of “postpartum haemorrhage prevention” strategy is more suitable for reasons of medical need, efficacy, or desirability—has emerged as an accepted and valuable alternative to haemorrhage treatment, thus swiftly affecting the rise in oxytocin industry value.
Moreover, leading healthcare organizations at national, regional and global level are recommending the use of oxytocin as prophylactic first-line treatment for the prevention and treatment of pregnancy and birth associated haemorrhage cases globally.
The market is expected to expand at a considerable growth rate over the next eight years at a CAGR of close to 9.0%, and offer an absolute $ opportunity of US$ 7.7 Mn from 2021-2022. The above mentioned factors compile the sales outlook of the global oxytocin market, and are expected to raise value in the overall healthcare industry.
Increasing healthcare expenditure and per capita income offers unique opportunity for leading oxytocin manufacturers to expand their presence in the emerging market such as Africa, China and India market.
Emerging scientific and technological advancements offers potential opportunities to expand the oxytocin indication to emerging applications such as pregnancy complication, autism, social anxiety and many others. These new indications are in development phases or being preferred to use off-label but in future they could offer potential growth opportunities.
Oxytocin therapeutic with incremental innovation such as high stability of formulation, development of new convenient dosage forms, high efficacy and potency versions are expected to provide potential opportunities for the leading companies in the global oxytocin market.
Most of the market opportunities in the global oxytocin market are present in developing region with complex nature of the market. In addition, the market is highly competitive and majorly operates by local players. Hence, the collaborative approach and partnership will offer high market penetration and growth opportunities.
The availability of alternate drugs like misoprostol and magnesium sulphate for labour induction or PPH treatment could hamper the growth of oxytocin market. Moreover, misoprostol available in tablet form unlike oxytocin which is in injection form, making product more stable and easily accessible for resource-poor countries.
Manufacturers in many countries are not obtaining WHO prequalification for manufacturing of oxytocin products. This leads to production of substandard quality of drugs in the market, thus, hampering its growth.
The current market structure where large number of manufacturers are creating high price-sensitive market. That makes this market less adherent to the required regulation owing to the cost involved in the upgradation of the manufacturing facilities.
Oxytocin has been used in the dairy farming sector to enhance lactation, to speed up the ripening of fruits and vegetables. The misuse of the drug can cause deterioration of milch cattle.
The increasing complaints and misuse of the oxytocin drugs resulted in a Government implied ban on all private sector companies for manufacturing and distributing oxytocin for domestic use in India without registration and cGMP practices.
The U.S. dominates the North American region with a total market share of about 91.5% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of this market is driven by increasing awareness regarding pregnancy products and increasing expenditure on personal care products within the country. The rising responsiveness has resulted in successful pregnancy-related awareness programs and maternal and child health has inducted itself as an essential element of the U.S. healthcare system.
Germany is set to exhibit a CAGR of about 6.6% in the European Oxytocin market during the forecast period. The country has essentially incorporated advanced maternity care, resulting in proliferation of sales in the European region for oxytocin products. Presence of large industry players with key research impact upon the overall market structure, such as Novartis, in the region is further expected to present Germany as a lucrative research, development and production hub for oxytocin products in the European region throughout the forecast period.
China holds 67.3% share in the East Asia market in 2021, and is projected to increase at a CAGR rate of 6.2% during the forecast period. The growth of the Oxytocin market in the country is attributed to the rising wave of automation and robotic assistive devices in the region of East Asia, with China as the prime contributor in the development industry for robotic devices for various intended uses, including Oxytocin for orthopaedic procedures. As a global manufacturing hub, China is likely to pose an increasing demand trend over the forecast period.
In 2021, Japan held a 26.0% share in the East Asia Oxytocin market, and is projected to expand at a CAGR of 6.9% from 2022 to 2030. The rising research interest in Japan for novel therapeutics and hormonal therapy have promoted the region of East Asia as upcoming in terms of generating spurred revenues globally.
Postpartum product types project a lucrative growth at a CAGR of 8.7% till the end of the forecast period, with a market share of over 88.8% in 2021. The applications and use of postpartum oxytocin products has resulted in the decrease of post-partum haemorrhage, and thus is being gradually adopted over the globe with a collective gain of lowered maternal mortality.
Hospital Pharmacies hold a revenue share of 63.8% in 2021 and are projected to hold a share over the forecast period with the estimation being 87.0%. A majority of procedures involving the use of Oxytocin are performed within the hospitals. Moreover, hospital networks promote the purchasing power for Oxytocin market and are thus dominant as a Distribution Channel segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The leading global oxytocin market players are focusing on research and development of innovative products with competitive advantages. The oxytocin market is a highly fragmented with a large number of local and multinational players operating in the market worldwide. The majority of the products in oxytocin market are procured from the local players by the national procurement agencies of the local governments.
Similarly, recent developments related to companies manufacturing Oxytocin products have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2030 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, China, Japan, South Korea, India, Malaysia, Indonesia, Thailand, Australia,New Zealand, GCC Countries, Turkey, Egypt, Nigeria, Algeria, Morocco, Kenya |
Key Market Segments Covered | Product Distribution Channel and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
By Product:
By Distribution Channel:
By Region:
The global Oxytocin market is worth US$ 76.0 Mn at present, and is set to expand 2X over the next eight years.
The Oxytocin market is expected to reach US$ 164.9 Mn by the end of 2030, with sales revenue expected to register 9.0% CAGR.
Highly fragmented market, increased licensing activities and WHO prequalification are some of the key trends being witnessed in this marketplace.
The China, U. S., India, Canada and Japan are expected to drive demand for Oxytocin products.
North America is one of the key markets for Oxytocin, with the U.S. expected to account over 90.8% of the North American market revenue share during the forecast period.
Demand for Oxytocin in Europe is expected to register growth of 9.2% over the next seven years.
The U.S., India and Canada are key producers of Oxytocin products.
Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International plc. (Par Sterile Products, LLC), Teva Pharmaceutical Industries Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation are the key exporters of Oxytocin market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Strategic Promotional Strategies 4.3. Regulatory Scenario 4.4. Disease Epidemiology 5. Global Oxytocin Market - Pricing Analysis 5.1. Regional Pricing Analysis By Indication 5.2. Pricing Break-up 5.2.1. Manufacturer Level Pricing 5.2.2. Distributor Level Pricing 5.3. Global Average Pricing Analysis Benchmark 6. Global Oxytocin Market Demand (in Volume) Analysis 2015-2021 and Forecast, 2022-2030 6.1. Historical Market Volume (Units Mn) Analysis, 2015-2021 6.2. Current and Future Market Volume (Units Mn) Projections, 2022-2030 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Oxytocin Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Expenditure Outlook 8.2. Forecast Factors - Relevance & Impact 8.2.1. Increasing Prevalence of Pregnancy Complications 8.2.2. Rising number of Birth Globally 8.2.3. Growing Awareness of Induced Labour and Breastfeeding 8.3. Value Chain 8.4. Market Dynamics 8.4.1. Drivers 8.4.2. Restraints 8.4.3. Opportunity Analysis 9. COVID19 Crisis Analysis 9.1. Current COVID19 Statistics and Probable Future Impact 9.2. Current GDP Projection and Probable Impact 9.3. Current Economic Projection as compared to 2008 financial analysis 9.4. COVID19 and Impact Analysis 9.4.1. Revenue By Product 9.4.2. Revenue By Country 9.5. 2020 Market Scenario 9.6. Quarter by Quarter Forecast 9.7. Projected recovery Quarter 9.8. Recovery Scenario – Short term, Midterm and Long Term Impact 10. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Indication 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 - 2021 10.3. Current and Future Market Size (US$ Mn) and Forecast By Indication, 2022 - 2030 10.3.1. Antepartum 10.3.2. Postpartum 10.4. Market Attractiveness Analysis By Indication 11. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2015 - 2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2030 11.3.1. Hospital Pharmacies 11.3.2. Drug Stores 11.3.3. Online Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2015 - 2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022 - 2030 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Middle East and Africa (MEA) 12.3.5. East Asia 12.3.6. South Asia 12.3.7. Oceania 12.4. Market Attractiveness Analysis by Region 13. North America Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 13.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 13.4.1. By Country 13.4.1.1. U.S. 13.4.1.2. Canada 13.4.2. By Indication 13.4.3. By Distribution Channel 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Indication 13.5.3. By Distribution Channel 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Latin America Oxytocin Market 2015-2021 and Forecast 2022-2030 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 14.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Argentina 14.4.1.4. Rest of Latin America 14.4.2. By Indication 14.4.3. By Distribution Channel 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Indication 14.5.3. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Europe Oxytocin Market 2015-2021 and Forecast 2022-2030 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 15.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. Italy 15.4.1.3. France 15.4.1.4. U.K. 15.4.1.5. Spain 15.4.1.6. BENELUX 15.4.1.7. Russia 15.4.1.8. Rest of Europe 15.4.2. By Indication 15.4.3. By Distribution Channel 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Indication 15.5.3. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. South Asia Oxytocin Market 2015-2021 and Forecast 2022-2030 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 16.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 16.4.1. By Country 16.4.1.1. India 16.4.1.2. Thailand 16.4.1.3. Indonesia 16.4.1.4. Malaysia 16.4.1.5. Rest of South Asia 16.4.2. By Indication 16.4.3. By Distribution Channel 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Indication 16.5.3. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. East Asia Oxytocin Market 2015-2021 and Forecast 2022-2030 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 17.4.1. By Country 17.4.1.1. China 17.4.1.2. Japan 17.4.1.3. South Korea 17.4.2. By Indication 17.4.3. By Distribution Channel 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Indication 17.5.3. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Oceania Oxytocin Market 2015-2021 and Forecast 2022-2030 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 18.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 18.4.1. By Country 18.4.1.1. Australia 18.4.1.2. New Zealand 18.4.2. By Indication 18.4.3. By Distribution Channel 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Indication 18.5.3. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Oxytocin Market 2015-2021 and Forecast 2022-2030 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021 19.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030 19.4.1. By Country 19.4.1.1. GCC Countries 19.4.1.2. South Africa 19.4.1.3. Egypt 19.4.1.4. Nigeria 19.4.1.5. Algeria 19.4.1.6. Morocco 19.4.1.7. Kenya 19.4.1.8. Rest of Middle East and Africa 19.4.2. By Indication 19.4.3. By Distribution Channel 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Indication 19.5.3. By Distribution Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Emerging & Key Countries Oxytocin Market Analysis 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Oxytocin Market Analysis 20.2.1. By Indication 20.2.2. By Distribution Channel 20.3. Canada Oxytocin Market Analysis 20.3.1. By Indication 20.3.2. By Distribution Channel 20.4. Mexico Oxytocin Market Analysis 20.4.1. By Indication 20.4.2. By Distribution Channel 20.5. Brazil Oxytocin Market Analysis 20.5.1. By Indication 20.5.2. By Distribution Channel 20.6. Argentina Oxytocin Market Analysis 20.6.1. By Indication 20.6.2. By Distribution Channel 20.7. Germany Oxytocin Market Analysis 20.7.1. By Indication 20.7.2. By Distribution Channel 20.8. Italy Oxytocin Market Analysis 20.8.1. By Indication 20.8.2. By Distribution Channel 20.9. France Oxytocin Market Analysis 20.9.1. By Indication 20.9.2. By Distribution Channel 20.10. U.K. Oxytocin Market Analysis 20.10.1. By Indication 20.10.2. By Distribution Channel 20.11. Spain Oxytocin Market Analysis 20.11.1. By Indication 20.11.2. By Distribution Channel 20.12. Russia Oxytocin Market Analysis 20.12.1. By Indication 20.12.2. By Distribution Channel 20.13. China Oxytocin Market Analysis 20.13.1. By Indication 20.13.2. By Distribution Channel 20.14. Japan Oxytocin Market Analysis 20.14.1. By Indication 20.14.2. By Distribution Channel 20.15. S. Korea Oxytocin Market Analysis 20.15.1. By Indication 20.15.2. By Distribution Channel 20.16. India Oxytocin Market Analysis 20.16.1. By Indication 20.16.2. By Distribution Channel 20.17. Malaysia Oxytocin Market Analysis 20.17.1. By Indication 20.17.2. By Distribution Channel 20.18. Thailand Oxytocin Market Analysis 20.18.1. By Indication 20.18.2. By Distribution Channel 20.19. Indonesia Oxytocin Market Analysis 20.19.1. By Indication 20.19.2. By Distribution Channel 20.20. Australia Oxytocin Market Analysis 20.20.1. By Indication 20.20.2. By Distribution Channel 20.21. New Zealand Oxytocin Market Analysis 20.21.1. By Indication 20.21.2. By Distribution Channel 20.22. GCC Countries Oxytocin Market Analysis 20.22.1. By Indication 20.22.2. By Distribution Channel 20.23. Turkey Oxytocin Market Analysis 20.23.1. By Indication 20.23.2. By Distribution Channel 20.24. South Africa Oxytocin Market Analysis 20.24.1. By Indication 20.24.2. By Distribution Channel 20.25. Egypt Oxytocin Market Analysis 20.25.1. By Indication 20.25.2. By Distribution Channel 20.26. Nigeria Oxytocin Market Analysis 20.26.1. By Indication 20.26.2. By Distribution Channel 20.27. Algeria Oxytocin Market Analysis 20.27.1. By Indication 20.27.2. By Distribution Channel 20.28. Morroco Oxytocin Market Analysis 20.28.1. By Indication 20.28.2. By Distribution Channel 20.29. Kenya Oxytocin Market Analysis 20.29.1. By Indication 20.29.2. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional Footprint of Players 21.4.2. Product Footprint by Players 21.4.3. Channel Footprint by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Pricing Analysis by Competition 22.3. Competition Benchmarking 22.4. Competition Deep Dive 22.5. Key Players Based On Estimated Tracked Revenue 22.5.1. Pfizer Inc. 22.5.1.1. Indication Portfolio 22.5.1.2. Profitability by Market Segments (Channel/Region) 22.5.1.3. Sales Footprint 22.5.1.4. Analyst commentary 22.5.1.5. Strategy Overview 22.5.1.5.1. Marketing Strategy 22.5.1.5.2. Product Strategy 22.5.1.5.3. Channel Strategy 22.5.2. Novartis AG 22.5.2.1. Indication Portfolio 22.5.2.2. Profitability by Market Segments (Channel/Region) 22.5.2.3. Sales Footprint 22.5.2.4. Analyst commentary 22.5.2.5. Strategy Overview 22.5.2.5.1. Marketing Strategy 22.5.2.5.2. Product Strategy 22.5.2.5.3. Channel Strategy 22.5.3. Ferring B.V. 22.5.3.1. Indication Portfolio 22.5.3.2. Profitability by Market Segments (Channel/Region) 22.5.3.3. Sales Footprint 22.5.3.4. Analyst commentary 22.5.3.5. Strategy Overview 22.5.3.5.1. Marketing Strategy 22.5.3.5.2. Product Strategy 22.5.3.5.3. Channel Strategy 22.5.4. Fresenius Kabi LLC 22.5.4.1. Indication Portfolio 22.5.4.2. Profitability by Market Segments (Channel/Region) 22.5.4.3. Sales Footprint 22.5.4.4. Analyst commentary 22.5.4.5. Strategy Overview 22.5.4.5.1. Marketing Strategy 22.5.4.5.2. Product Strategy 22.5.4.5.3. Channel Strategy 22.5.5. Hikma Pharmaceuticals PLC 22.5.5.1. Indication Portfolio 22.5.5.2. Profitability by Market Segments (Channel/Region) 22.5.5.3. Sales Footprint 22.5.5.4. Analyst commentary 22.5.5.5. Strategy Overview 22.5.5.5.1. Marketing Strategy 22.5.5.5.2. Product Strategy 22.5.5.5.3. Channel Strategy 22.5.6. Endo International plc. (Par Sterile Products, LLC) 22.5.6.1. Indication Portfolio 22.5.6.2. Profitability by Market Segments (Channel/Region) 22.5.6.3. Sales Footprint 22.5.6.4. Analyst commentary 22.5.6.5. Strategy Overview 22.5.6.5.1. Marketing Strategy 22.5.6.5.2. Product Strategy 22.5.6.5.3. Channel Strategy 22.5.7. Teva Pharmaceutical Industries Ltd. 22.5.7.1. Indication Portfolio 22.5.7.2. Profitability by Market Segments (Channel/Region) 22.5.7.3. Sales Footprint 22.5.7.4. Analyst commentary 22.5.7.5. Strategy Overview 22.5.7.5.1. Marketing Strategy 22.5.7.5.2. Product Strategy 22.5.7.5.3. Channel Strategy 22.5.8. Mylan N.V. 22.5.8.1. Indication Portfolio 22.5.8.2. Profitability by Market Segments (Channel/Region) 22.5.8.3. Sales Footprint 22.5.8.4. Analyst commentary 22.5.8.5. Strategy Overview 22.5.8.5.1. Marketing Strategy 22.5.8.5.2. Product Strategy 22.5.8.5.3. Channel Strategy 22.5.9. Wockhardt Ltd. 22.5.9.1. Indication Portfolio 22.5.9.2. Profitability by Market Segments (Channel/Region) 22.5.9.3. Sales Footprint 22.5.9.4. Analyst commentary 22.5.9.5. Strategy Overview 22.5.9.5.1. Marketing Strategy 22.5.9.5.2. Product Strategy 22.5.9.5.3. Channel Strategy 22.5.10. Sun Pharmaceutical Industries Ltd. 22.5.10.1. Indication Portfolio 22.5.10.2. Profitability by Market Segments (Channel/Region) 22.5.10.3. Sales Footprint 22.5.10.4. Analyst commentary 22.5.10.5. Strategy Overview 22.5.10.5.1. Marketing Strategy 22.5.10.5.2. Product Strategy 22.5.10.5.3. Channel Strategy 22.5.11. Yuhan Corporation 22.5.11.1. Indication Portfolio 22.5.11.2. Profitability by Market Segments (Channel/Region) 22.5.11.3. Sales Footprint 22.5.11.4. Analyst commentary 22.5.11.5. Strategy Overview 22.5.11.5.1. Marketing Strategy 22.5.11.5.2. Product Strategy 22.5.11.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Table 01: Global Oxytocin Market Volume (‘000 Units of 10 IU Doses) Analysis and Opportunity Assessment 2015–2030, By Region Table 02: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 03: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 04: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region Table 05: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 06: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 07: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 08: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 09: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 10: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 11: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 12: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 13: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 14: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 15: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 16: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 17: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 18: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 19: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 20: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 21: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 22: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 23: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 24: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 25: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Figure 01: Oxytocin Pricing Analysis (US$) for Per 10 IU Dose, By Region, 2019 Figure 02: Global Oxytocin Market Volume (in 000' Units of 10 IU Doses) Analysis, 2015-2021 Figure 03: Global Oxytocin Market Volume Forecast (in 000' Units of 10 IU Doses), 2022-2030 Figure 04: Global Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 05: Global Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 06: Global Oxytocin Market Absolute $ Opportunity, 2022 - 2030 Figure 07: Global Oxytocin Market Share Analysis (%), By Indication, 2022-2030 Figure 08: Global Oxytocin Market Y-o-Y Analysis (%), By Indication, 2022-2030 Figure 09: Global Oxytocin Market Attractiveness Analysis By Indication, 2022-2030 Figure 10: Global Oxytocin Market Share Analysis (%), By Distribution Channel, 2022-2030 Figure 11: Global Oxytocin Market Y-o-Y Analysis (%), By Distribution Channel, 2022-2030 Figure 12: Global Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030 Figure 13: Global Oxytocin Market Share Analysis (%), By Region, 2022-2030 Figure 14: Global Oxytocin Market Y-o-Y Analysis (%), By Region, 2022-2030 Figure 15: Global Oxytocin Market Attractiveness Analysis by Region, 2022-2030 Figure 16: North America Oxytocin Market Value Share, By Indication, 2022 (E) Figure 17: North America Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 18: North America Oxytocin Market Value Share, By Country, 2022 (E) Figure 19: North America Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 20: North America Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 21: North America Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 22: North America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030 Figure 23: North America Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 24: Latin America Oxytocin Market Value Share, By Indication, 2022 (E) Figure 25: Latin America Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 26: Latin America Oxytocin Market Value Share, By Country, 2022 (E) Figure 27: Latin America Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 28: Latin America Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 29: Latin America Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 30: Latin America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030 Figure 31: Latin America Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 32: Europe Oxytocin Market Value Share, By Indication, 2022 (E) Figure 33: Europe Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 34: Europe Oxytocin Market Value Share, By Country, 2020 (E Figure 35: Europe Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 36: Europe Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 37: Europe Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 38: Europe Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030 Figure 39: Europe Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 40: South Asia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 41: South Asia Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 42: South Asia Oxytocin Market Value Share, By Country, 2022 (E) Figure 43: South Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 44: South Asia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 45: South Asia Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 46: South Asia Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030 Figure 47: South Asia Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 48: East Asia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 50: East Asia Oxytocin Market Value Share, By Country, 2022 (E) Figure 51: East Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 52: East Asia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 53: East Asia Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 55: East Asia Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 56: Oceania Oxytocin Market Value Share, By Indication, 2022 (E) Figure 58: Oceania Oxytocin Market Value Share, By Country, 2022 (E) Figure 59: Oceania Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 60: Oceania Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 61: Oceania Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 63: Oceania Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 64: Middle East and Africa Oxytocin Market Value Share, By Indication, 2022 (E) Figure 66: Middle East and Africa Oxytocin Market Value Share, By Country, 2022 (E) Figure 67: Middle East and Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 68: Middle East and Africa Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 69: Middle East and Africa Oxytocin Market Attractiveness Analysis by Indication, 2022-2030 Figure 70: Middle East and Africa Oxytocin Market Attractiveness Analysis by Country, 2022-2030 Figure 71: U.S. Oxytocin Market Value Share, By Indication, 2022 (E) Figure 72: U.S. Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 73: U.S. Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 74: U.S Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 75: U.S Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 76: Canada Oxytocin Market Value Share, By Indication, 2022 (E) Figure 78: Canada Oxytocin Market Value Share, By Distribution Channel, 2022 (E) Figure 79: Canada Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 80: Canada Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 81: Canada Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 82: Mexico Oxytocin Market Value Share, By Indication, 2022 (E) Figure 84: Mexico Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 85: Mexico Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 86: Mexico Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 87: Brazil Oxytocin Market Value Share, By Indication, 2022 (E) Figure 89: Brazil Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 90: Brazil Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 91: Brazil Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 92: Argentina Oxytocin Market Value Share, By Indication, 2022 (E) Figure 94: Argentina Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 95: Argentina Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 96: Argentina Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 97: Germany Oxytocin Market Value Share, By Indication, 2022 (E) Figure 99: Germany Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 100: Germany Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 101: Germany Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 102: Italy Oxytocin Market Value Share, By Indication, 2022 (E) Figure 104: Italy Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 105: Italy Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 106: Italy Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 107: France Oxytocin Market Value Share, By Indication, 2022 (E) Figure 109: France Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 110: France Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 111: France Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 112: U.K. Oxytocin Market Value Share, By Indication, 2022 (E) Figure 114: U.K. Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 115: U.K. Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 116: U.K. Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 117: Spain Oxytocin Market Value Share, By Indication, 2022 (E) Figure 119: Spain Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 120: Spain Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 121: Spain Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 122: Russia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 124: Russia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 125: Russia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 126: Russia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 127: China Oxytocin Market Value Share, By Indication, 2022 (E) Figure 129: China Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 130: China Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 131: China Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 132: Japan Oxytocin Market Value Share, By Indication, 2022 (E) Figure 134: Japan Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 135: Japan Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 136: Japan Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 137: South Korea Oxytocin Market Value Share, By Indication, 2022 (E) Figure 139: South Korea Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 140: South Korea Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 141: South Korea Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 142: India Oxytocin Market Value Share, By Indication, 2022 (E) Figure 144: India Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 145: India Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 146: India Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 147: Malaysia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 149: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 150: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 151: Malaysia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 152: Thailand Oxytocin Market Value Share, By Indication, 2022 (E) Figure 154: Thailand Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 155: Thailand Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 156: Thailand Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 157: Indonesia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 159: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 160: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 161: Indonesia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 162: Australia Oxytocin Market Value Share, By Indication, 2022 (E) Figure 164: Australia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 165: Australia Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 166: Australia Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 167: New Zealand Oxytocin Market Value Share, By Indication, 2022 (E) Figure 169: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 170: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 171: New Zealand Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 172: GCC Countries Oxytocin Market Value Share, By Indication, 2022 (E) Figure 174: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 175: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 176: GCC Countries Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 177: Turkey Oxytocin Market Value Share, By Indication, 2022 (E) Figure 179: Turkey Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 180: Turkey Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 181: Turkey Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 182: South Africa Oxytocin Market Value Share, By Indication, 2022 (E) Figure 184: South Africa Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 185: South Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 186: South Africa Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 187: Egypt Oxytocin Market Value Share, By Indication, 2022 (E) Figure 189: Egypt Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 190: Egypt Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 191: Egypt Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 192: Nigeria Oxytocin Market Value Share, By Indication, 2022 (E) Figure 194: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 195: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 196: Nigeria Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 197: Algeria Oxytocin Market Value Share, By Indication, 2022 (E) Figure 199: Algeria Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 200: Algeria Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 201: Algeria Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 202: Morroco Oxytocin Market Value Share, By Indication, 2022 (E) Figure 204: Morroco Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 205: Morroco Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 206: Morroco Oxytocin Market Value Forecast (US$ Mn), 2022-2030 Figure 207: Kenya Oxytocin Market Value Share, By Indication, 2022 (E) Figure 209: Kenya Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030 Figure 210: Kenya Oxytocin Market Value Analysis (US$ Mn), 2015-2021 Figure 211: Kenya Oxytocin Market Value Forecast (US$ Mn), 2022-2030
Recommendations
Explore Healthcare Insights
View Reports